Published in Neurology on May 01, 1996
Parkinson's disease and residential exposure to maneb and paraquat from agricultural applications in the central valley of California. Am J Epidemiol (2009) 3.02
Association of pesticide exposure with neurologic dysfunction and disease. Environ Health Perspect (2004) 2.79
Pesticides and Parkinson's disease--is there a link? Environ Health Perspect (2006) 2.01
Pesticide exposure and risk of Parkinson's disease: a family-based case-control study. BMC Neurol (2008) 1.76
Dietary and lifestyle variables in relation to incidence of Parkinson's disease in Greece. Eur J Epidemiol (2013) 1.72
Traumatic brain injury in later life increases risk for Parkinson disease. Ann Neurol (2015) 1.71
Parkinson's disease risk from ambient exposure to pesticides. Eur J Epidemiol (2011) 1.70
Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein. Curr Protein Pept Sci (2009) 1.66
Industrial toxicants and Parkinson's disease. Neurotoxicology (2012) 1.65
Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study. Occup Environ Med (2007) 1.60
Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ Health Perspect (2003) 1.47
Risk of Parkinson's disease after hospital contact for head injury: population based case-control study. BMJ (2008) 1.42
The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons. Neurobiol Dis (2010) 1.31
Neurodegenerative diseases: an overview of environmental risk factors. Environ Health Perspect (2005) 1.30
Paraoxonase 1, agricultural organophosphate exposure, and Parkinson disease. Epidemiology (2010) 1.30
Occupational factors and risk of Parkinson's disease: A population-based case-control study. Am J Ind Med (2010) 1.26
Is pesticide use related to Parkinson disease? Some clues to heterogeneity in study results. Environ Health Perspect (2012) 1.22
Persistent organochlorine pesticides in serum and risk of Parkinson disease. Neurology (2010) 1.17
Traumatic brain injury, paraquat exposure, and their relationship to Parkinson disease. Neurology (2012) 1.17
Geographic model and biomarker-derived measures of pesticide exposure and Parkinson's disease. Ann N Y Acad Sci (2006) 1.14
Head injury, α-synuclein Rep1, and Parkinson's disease. Ann Neurol (2012) 1.14
Epidemiology of mild traumatic brain injury and neurodegenerative disease. Mol Cell Neurosci (2015) 1.10
Solvent neurotoxicity. Occup Environ Med (2006) 1.07
Low levels of arsenite activates nuclear factor-kappaB and activator protein-1 in immortalized mesencephalic cells. J Biochem Mol Toxicol (2005) 1.03
Parkinsonism and occupational exposure to pesticides. Occup Environ Med (2001) 1.03
Parkinson's disease and other basal ganglia or movement disorders in a large nationwide cohort of Swedish welders. Occup Environ Med (2006) 1.01
Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity. BMC Neurosci (2005) 1.01
Job exposure matrix (JEM)-derived estimates of lifetime occupational pesticide exposure and the risk of Parkinson's disease. Arch Environ Occup Health (2014) 1.00
Generalizability: the trees, the forest, and the low-hanging fruit. Neurology (2012) 0.99
Pathogenesis of Parkinson disease-the gut-brain axis and environmental factors. Nat Rev Neurol (2015) 0.98
Household organophosphorus pesticide use and Parkinson's disease. Int J Epidemiol (2013) 0.98
Is dental amalgam safe for humans? The opinion of the scientific committee of the European Commission. J Occup Med Toxicol (2011) 0.92
Parkinson's disease as a result of aging. Aging Cell (2015) 0.92
Mitochondrial DNA polymorphisms in pathologically proven Parkinson's disease. J Neurol (1997) 0.90
Gene therapy in Parkinson's disease: rationale and current status. CNS Drugs (2010) 0.89
Mortality from Parkinson's disease and other causes among a workforce manufacturing paraquat: a retrospective cohort study. BMJ Open (2011) 0.89
Alteration of dopamine uptake into rat striatal vesicles and synaptosomes caused by an in vitro exposure to atrazine and some of its metabolites. Toxicology (2008) 0.88
Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity. Front Aging Neurosci (2014) 0.88
Functional paraoxonase 1 variants modify the risk of Parkinson's disease due to organophosphate exposure. Environ Int (2013) 0.88
Parkinson's disease genetics comes of age. BMJ (1999) 0.87
Associations of welding and manganese exposure with Parkinson disease: review and meta-analysis. Neurology (2012) 0.87
Association of traumatic brain injury with subsequent neurological and psychiatric disease: a meta-analysis. J Neurosurg (2015) 0.86
A prospective analysis of airborne metal exposures and risk of Parkinson disease in the nurses' health study cohort. Environ Health Perspect (2014) 0.86
Association between Parkinson's Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis. PLoS One (2016) 0.85
Solvents and Parkinson disease: a systematic review of toxicological and epidemiological evidence. Toxicol Appl Pharmacol (2012) 0.85
MDR1 variants and risk of Parkinson disease. Association with pesticide exposure? J Neurol (2009) 0.85
High prevalence of extrapyramidal signs and symptoms in a group of Italian dental technicians. BMC Neurol (2007) 0.83
alpha-Synuclein: a therapeutic target for Parkinson's disease? Pharmacol Res (2008) 0.82
Considerations on the role of environmental toxins in idiopathic Parkinson's disease pathophysiology. Transl Neurodegener (2014) 0.80
Examining the relationship between head trauma and neurodegenerative disease: A review of epidemiology, pathology and neuroimaging techniques. J Alzheimers Dis Parkinsonism (2014) 0.80
Occupational risk factors for Parkinson's disease: a case-control study in Japan. BMC Neurol (2011) 0.79
Study of familial Parkinson's disease in Russia, Uzbekistan, and Zambia. Postgrad Med J (2005) 0.79
Concerted action of metals and macromolecular crowding on the fibrillation of alpha-synuclein. Protein Pept Lett (2008) 0.78
Association between parkinsonism and participation in agriculture in Korea. J Clin Neurol (2008) 0.78
The effects of piroxicam in the attenuation of MPP+/MPTP toxicity in vitro and in vivo. Neurochem Res (2008) 0.77
Biophysical Characterization of α-Synuclein and Rotenone Interaction. Biomolecules (2013) 0.77
Environmental Exposures and Parkinson's Disease. Int J Environ Res Public Health (2016) 0.77
How does an occupational neurologist assess welders and steelworkers for a manganese-induced movement disorder? An international team's experiences in Guanxi, China, part I. J Occup Environ Med (2012) 0.76
Use of job-exposure matrices to estimate occupational exposure to pesticides: A review. J Expo Sci Environ Epidemiol (2016) 0.76
Disease-Toxicant Interactions in Parkinson's Disease Neuropathology. Neurochem Res (2016) 0.76
Association between History of Dental Amalgam Fillings and Risk of Parkinson's Disease: A Population-Based Retrospective Cohort Study in Taiwan. PLoS One (2016) 0.75
Research in Parkinson's disease in India: A review. Ann Indian Acad Neurol (2016) 0.75
Younger age at onset of sporadic Parkinson's disease among subjects occupationally exposed to metals and pesticides. Interdiscip Toxicol (2014) 0.75
Coherent and Contradictory Facts, Feats and Fictions Associated with Metal Accumulation in Parkinson's Disease: Epicenter or Outcome, Yet a Demigod Question. Mol Neurobiol (2016) 0.75
Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med (2013) 6.37
Three-point Dixon technique for true water/fat decomposition with B0 inhomogeneity correction. Magn Reson Med (1991) 5.06
The ubiquitin pathway in Parkinson's disease. Nature (1998) 4.48
The osteoarthritis initiative: report on the design rationale for the magnetic resonance imaging protocol for the knee. Osteoarthritis Cartilage (2008) 4.39
Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology (1998) 3.95
Animal models for implant biomaterial research in bone: a review. Eur Cell Mater (2007) 3.48
Transcatheter closure of patent foramen ovale after presumed paradoxical embolism. Circulation (1992) 3.04
The role of radiotracer imaging in Parkinson disease. Neurology (2005) 3.02
High, usual and impaired functioning in community-dwelling older men and women: findings from the MacArthur Foundation Research Network on Successful Aging. J Clin Epidemiol (1993) 2.77
Double echo steady state magnetic resonance imaging of knee articular cartilage at 3 Tesla: a pilot study for the Osteoarthritis Initiative. Ann Rheum Dis (2005) 2.76
Imprinted X inactivation maintained by a mouse Polycomb group gene. Nat Genet (2001) 2.63
Translation and mRNA decay. Mol Gen Genet (1978) 2.40
Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience (1994) 2.40
Genotype-based screen for ENU-induced mutations in mouse embryonic stem cells. Nat Genet (2000) 2.24
Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's disease. J Neurol Neurosurg Psychiatry (2004) 2.12
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord (2000) 2.10
Pandemic influenza A(H1N1) 2009 breakthrough infections and estimates of vaccine effectiveness in Germany 2009-2010. Euro Surveill (2010) 1.95
A cluster of invasive meningococcal disease in young men who have sex with men in Berlin, October 2012 to May 2013. Euro Surveill (2013) 1.93
Epidemiologic study of 203 sibling pairs with Parkinson's disease: the GenePD study. Neurology (2002) 1.90
A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet (1998) 1.84
DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease. Neurology (2004) 1.83
Duration and frequency of every day activities in total hip patients. J Biomech (2001) 1.80
Intravenous levetiracetam in the treatment of benzodiazepine refractory status epilepticus. J Neurol Neurosurg Psychiatry (2007) 1.80
Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology (2000) 1.76
Static mechanical hyperalgesia without dynamic tactile allodynia in patients with restless legs syndrome. Brain (2004) 1.75
Transdermal nicotine in PD: a randomized, double-blind, placebo-controlled study. Neurology (2001) 1.71
Two year longitudinal change and test-retest-precision of knee cartilage morphology in a pilot study for the osteoarthritis initiative. Osteoarthritis Cartilage (2007) 1.71
DTI reveals hypothalamic and brainstem white matter lesions in patients with idiopathic narcolepsy. Sleep Med (2012) 1.68
Diet and Parkinson's disease. II: A possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study. Neurology (1996) 1.68
The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy? Arch Neurol (1999) 1.66
Tandem chromosomal duplications: role of REP sequences in the recombination event at the join-point. EMBO J (1990) 1.66
Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment. Drug Alcohol Depend (2006) 1.65
Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis: the importance of concomitant arterial and venous disease. J Vasc Surg (2000) 1.65
Self rating of health is associated with stressful life events, social support and residency in East and West Berlin shortly after the fall of the wall. J Epidemiol Community Health (2000) 1.60
NAD+ binding to the Escherichia coli K(+)-uptake protein TrkA and sequence similarity between TrkA and domains of a family of dehydrogenases suggest a role for NAD+ in bacterial transport. Mol Microbiol (1993) 1.56
Five subtypes of type A gamma-aminobutyric acid receptors identified in neurons by double and triple immunofluorescence staining with subunit-specific antibodies. Proc Natl Acad Sci U S A (1992) 1.55
A point mutation in PTPRC is associated with the development of multiple sclerosis. Nat Genet (2000) 1.54
Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients. Clin Cancer Res (1999) 1.54
Effective cabergoline treatment in idiopathic restless legs syndrome. Neurology (2004) 1.51
Perineuronal nets provide a polyanionic, glia-associated form of microenvironment around certain neurons in many parts of the rat brain. Glia (1993) 1.49
The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect (2004) 1.49
Incidence of status epilepticus in adults in Germany: a prospective, population-based study. Epilepsia (2001) 1.49
Detection of respiratory syncytial virus RNA in blood of neonates by polymerase chain reaction. J Med Virol (1998) 1.48
Fibromuscular hyperplasia: extension of the disease and therapeutic outcome. Results of the University Hospital Zurich Cooperative Study on Fibromuscular Hyperplasia. Nephron (1986) 1.47
Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J Natl Cancer Inst (1999) 1.46
CNS involvement in hereditary neuropathy with pressure palsies (HNPP). Neurology (2006) 1.44
Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. J Neurosci (1986) 1.43
Radiological analysis of normal axial alignment of femur and tibia in view of total knee arthroplasty. J Arthroplasty (1993) 1.43
The heart in sickle cell anemia. The Cooperative Study of Sickle Cell Disease (CSSCD). Chest (1995) 1.42
Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial parkinsonism associated with mutations in the parkin gene. Ann Neurol (2001) 1.42
Effectiveness of colorectal cancer screening: results from a population-based case-control evaluation in Saarland, Germany. Eur J Cancer Prev (1993) 1.41
[Clinical relevance of signal-intense foci in cerebral magnetic resonance tomography in neurofibromatosis]. Fortschr Neurol Psychiatr (1991) 1.40
Prediction of the effects and costs of breast-cancer screening in Germany. Int J Cancer (1994) 1.40
Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. Ann Neurol (2000) 1.40
Production of a specific antiserum to rat brain glutamic acid decarboxylase by injection of an antigen-antibody complex. Neuroscience (1981) 1.40
Cost of beta-adrenergic receptor blocking agents for ocular hypertension. Arch Ophthalmol (1992) 1.39
Animal models for fracture treatment in osteoporosis. Osteoporos Int (2005) 1.39
[Influencing of mitosis rate in endometrial carcinomas using 17-hydroxynorprogesterone capronate in women]. Arch Gynakol (1972) 1.38
Acute mesenteric ischemia caused by spontaneous isolated dissection of the superior mesenteric artery: treatment by percutaneous stent placement. Eur Radiol (2000) 1.38
All three subunits are required for the reconstitution of an active proton channel (F0) of Escherichia coli ATP synthase (F1F0). EMBO J (1985) 1.36
Large scale purification, nucleotide binding properties, and ATPase activity of the MalK subunit of Salmonella typhimurium maltose transport complex. J Biol Chem (1992) 1.35
Estimation of mechanical properties of cortical bone by computed tomography. J Orthop Res (1991) 1.34
High mutation rate in dopa-responsive dystonia: detection with comprehensive GCHI screening. Neurology (2005) 1.34
IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells. J Immunol (2001) 1.33
Fas/Fas ligand interactions promote activation-induced cell death of NK T lymphocytes. J Immunol (2000) 1.32
Bacterial adenosine 5'-triphosphate synthase (F1F0): purification and reconstitution of F0 complexes and biochemical and functional characterization of their subunits. Microbiol Rev (1987) 1.32
Activation mapping in essential tremor with functional magnetic resonance imaging. Ann Neurol (1997) 1.30
Patterns of cerebrospinal fluid pathology correlate with disease progression in multiple sclerosis. Brain (2001) 1.30
A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement. J Immunol (1999) 1.27
Early temporary porosis of bone induced by internal fixation implants. A reaction to necrosis, not to stress protection? Clin Orthop Relat Res (1988) 1.27
Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradication. Helicobacter (1998) 1.27
Implementation of the DOTS strategy for tuberculosis control in rural Kiboga District, Uganda, offering patients the option of treatment supervision in the community, 1998-1999. Int J Tuberc Lung Dis (2003) 1.26
Genome-wide scan for Parkinson's disease: the GenePD Study. Neurology (2001) 1.25
A study of five candidate genes in Parkinson's disease and related neurodegenerative disorders. European Study Group on Atypical Parkinsonism. Neurology (1999) 1.25
Men and women are different: diffusion tensor imaging reveals sexual dimorphism in the microstructure of the thalamus, corpus callosum and cingulum. Neuroimage (2010) 1.24
Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease. Eur J Neurol (2013) 1.24
Functional consequences of mutations in the conserved 'signature sequence' of the ATP-binding-cassette protein MalK. Eur J Biochem (1999) 1.23
Cerebral generators involved in the pathogenesis of the restless legs syndrome. Ann Neurol (1997) 1.23
Internal forces and moments in the femur during walking. J Biomech (1997) 1.22
ATP modulates subunit-subunit interactions in an ATP-binding cassette transporter (MalFGK2) determined by site-directed chemical cross-linking. J Biol Chem (2000) 1.22
The ATP-binding cassette (ABC) transporter for maltose/maltodextrins of Salmonella typhimurium. Characterization of the ATPase activity associated with the purified MalK subunit. J Biol Chem (1993) 1.21
Starnberg trial on epidemiology of Parkinsonism and hypertension in the elderly. Prevalence of Parkinson's disease and related disorders assessed by a door-to-door survey of inhabitants older than 65 years. Arch Neurol (1995) 1.21
Influence of muscle forces on femoral strain distribution. J Biomech (1998) 1.19
Uncertain identity of doxorubicin-resistant MCF-7 cell lines expressing mutated p53. J Natl Cancer Inst (2000) 1.19
Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics (2001) 1.18
Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain (2000) 1.18
Principles of fixation of osteoporotic fractures. J Bone Joint Surg Br (2006) 1.17
Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patients. J Neurol Neurosurg Psychiatry (1997) 1.17
Mitomycin C induces apoptosis and caspase-8 and -9 processing through a caspase-3 and Fas-independent pathway. Cell Death Differ (2002) 1.16
[Do female medical graduates have different views on professional work and workload compared to their male colleagues? Results of a multicenter postal survey in Germany]. Dtsch Med Wochenschr (2012) 1.16
Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study. J Neurol Neurosurg Psychiatry (1999) 1.16
Cell-specific immuno-probes for the brain of normal and mutant Drosophila melanogaster. I. Wildtype visual system. Cell Tissue Res (1988) 1.16